Home > News > Biophan Files SEC Form 8-K
March 30th, 2005
Biophan Files SEC Form 8-K
Abstract:
Biophan Technologies, Inc., a developer of next-generation biomedical technology, today filed an SEC Form 8-K containing the transcript of a recent online interview given by Company CEO Michael Weiner. In the interview, Mr. Weiner states that the newly filed and issued patents are part of Biophan's continued strategy to build a market-dominating "patent thicket."
Source:
businesswire
Bookmark:
| Related News Press |
Announcements
FSU researchers develop new methods to generate and improve magnetism of 2D materials December 13th, 2024
Innovative biomimetic superhydrophobic coating combines repair and buffering properties for superior anti-erosion December 13th, 2024
Groundbreaking research unveils unified theory for optical singularities in photonic microstructures December 13th, 2024
Patents/IP/Tech Transfer/Licensing
Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023
Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021
Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||